GlycoMimetics
- Pharmaceutical Preparations
- Rockville, Maryland
Compensation history
Top executives at GlycoMimetics received an average of $1M per person in annual compensation from 2013 to 2023.
Average pay of disclosed executives at GlycoMimetics
By year
Executives
We found seven executives who work or worked at GlycoMimetics.
Harout Semerjian
GlycoMimetics
Chief Executive Officer
Brian Hahn
GlycoMimetics
Chief Financial Officer
Edwin Rock
GlycoMimetics
Chief Medical Officer
Armand Girard
GlycoMimetics
Former Chief Business Officer and Senior Vice President
Rachel King
GlycoMimetics
Chief Executive Officer
John Magnani
GlycoMimetics
Chief Scientific Officer
Helen Thackray
GlycoMimetics
Chief Medical Officer
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2019 pay slips 16% to $2.7M
April 16, 2020
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019
About GlycoMimetics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address9708 Medical Center Drive, Rockville, Maryland 20850
- Phone240-243-1201
- Fiscal year endDecember 31
Source: SEC filings on April 1, 2024, April 21, 2023, April 11, 2022, April 16, 2020, April 10, 2019, April 13, 2018, April 20, 2017, April 11, 2016, and June 15, 2015.